U.S. Lobbyists Prepare to Seize “Historic Opportunity” in Tory-Led Brexit to Shred Consumer Safeguards, Raise Drug Prices

@theintercept.com 5 years ago

The Brexit deal may be a Trojan horse for U.S. corporate interests, from Silicon Valley and American pork to pharmaceuticals.